Your browser doesn't support javascript.
loading
Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.
Zecchini, Vincent; Madhu, Basetti; Russell, Roslin; Pértega-Gomes, Nelma; Warren, Anne; Gaude, Edoardo; Borlido, Joana; Stark, Rory; Ireland-Zecchini, Heather; Rao, Roheet; Scott, Helen; Boren, Joan; Massie, Charlie; Asim, Mohammad; Brindle, Kevin; Griffiths, John; Frezza, Christian; Neal, David E; Mills, Ian G.
Affiliation
  • Zecchini V; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK vinny.zecchini@cruk.cam.ac.uk.
  • Madhu B; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Russell R; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Pértega-Gomes N; Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Braga, Portugal.
  • Warren A; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Gaude E; Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
  • Borlido J; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Stark R; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Ireland-Zecchini H; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Rao R; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Scott H; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Boren J; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Massie C; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Asim M; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Brindle K; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Griffiths J; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Frezza C; Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
  • Neal DE; Department of CRUK, CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Mills IG; Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership University of Oslo and Oslo University Hospital, Oslo, Norway Department of Cancer Prevention and Urology, Institute of Cancer Research and Oslo University Hospital, Oslo, Norway.
EMBO J ; 33(12): 1365-82, 2014 Jun 17.
Article in En | MEDLINE | ID: mdl-24837709
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Arrestins / Hypoxia-Inducible Factor 1, alpha Subunit / Metabolic Networks and Pathways / Models, Biological Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: EMBO J Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Arrestins / Hypoxia-Inducible Factor 1, alpha Subunit / Metabolic Networks and Pathways / Models, Biological Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: EMBO J Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom